We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+6.58%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$2.31B
AUM Growth
+$134M
Cap. Flow
+$22M
Cap. Flow %
0.95%
Top 10 Hldgs %
15.69%
Holding
710
New
110
Increased
277
Reduced
245
Closed
75

Top Sells

Rank Stock Value
1
MAT icon
Mattel
MAT
+$11.6M
2
CYH icon
Community Health Systems
CYH
+$11.1M
3
KLAC icon
KLA
KLAC
+$8.56M
4
XRX icon
Xerox
XRX
+$8.27M
5
ESV
Ensco Rowan plc
ESV
+$8.03M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Industrials 11.86%
3 Technology 11%
4 Healthcare 9.52%
5 Consumer Staples 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
426
Bio-Rad Laboratories Class A
BIO
$9.42B
$394K 0.02%
3,354
-1,329
-28% -$157K
CONN
427
DELISTED
Conn's Inc.
CONN
$394K 0.02%
7,880
-276
-3% -$16.3K
AORT icon
428
Artivion
AORT
$1.32B
$392K 0.02%
55,933
+18,818
+51% +$127K
SAIA icon
429
Saia
SAIA
$9.72B
$392K 0.02%
12,574
-1,518
-11% -$47.2K
NCI
430
DELISTED
Navigant Consulting, Inc.
NCI
$391K 0.02%
25,260
+10,978
+77% +$154K
BOKF icon
431
BOK Financial
BOKF
$8.74B
$390K 0.02%
6,157
+1,067
+21% +$70.3K
ADUS icon
432
Addus HomeCare
ADUS
$2.23B
$388K 0.02%
13,392
-484
-3% -$10.9K
SAFM
433
DELISTED
Sanderson Farms Inc
SAFM
$387K 0.02%
5,931
-359
-6% -$24.8K
UTMD icon
434
Utah Medical Products
UTMD
$225M
$384K 0.02%
+6,465
New +$353K
HSP
435
DELISTED
HOSPIRA INC
HSP
$383K 0.02%
+9,764
New +$389K
TRMK icon
436
Trustmark
TRMK
$2.75B
$382K 0.02%
14,917
+2,051
+16% +$53.6K
DDS icon
437
Dillards
DDS
$9.56B
$380K 0.02%
4,852
-2,245
-32% -$182K
LEG icon
438
Leggett & Platt
LEG
$1.31B
$380K 0.02%
12,593
-21,587
-63% -$663K
HOT
439
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$379K 0.02%
5,697
+1,056
+23% +$69.9K
AVD icon
440
American Vanguard Corp
AVD
$68.9M
$378K 0.02%
14,058
+195
+1% +$4.93K
MYGN icon
441
Myriad Genetics
MYGN
$312M
$378K 0.02%
16,088
-854
-5% -$24.3K
AROC icon
442
Archrock
AROC
$5.8B
$375K 0.02%
13,609
-765
-5% -$22.4K
PBH icon
443
Prestige Consumer Healthcare
PBH
$2.6B
$375K 0.02%
+12,462
New +$407K
RH icon
444
RH
RH
$3.71B
$375K 0.02%
5,925
-233
-4% -$16.1K
WSBC icon
445
WesBanco
WSBC
$4B
$375K 0.02%
12,610
-424
-3% -$12.4K
PTR
446
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$375K 0.02%
3,409
-27
-0.8% -$3.09K
EXAR
447
DELISTED
Exar Corporation
EXAR
$375K 0.02%
27,959
+13,955
+100% +$177K
CTCT
448
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$374K 0.02%
15,813
-539
-3% -$10.3K
DMC
449
Del Monte Corp
DMC
$1.45B
$373K 0.02%
+12,576
New +$366K
DOC icon
450
Healthpeak Properties
DOC
$14.8B
$372K 0.02%
9,983
+2,552
+34% +$99.5K

Similar funds

Zacks Investment Management's Q3 2013 Portfolio in Review

As of Q3 2013, Zacks Investment Management held 710 positions worth $2.31B, up 6.2% from $2.18B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Zacks Investment Management's Q3 2013 filing shows 110 new, 277 increased, 245 reduced and 75 closed positions. Its largest new stake was PNC Financial Services: 123,980 shares worth $8.98M. The largest sale was Mattel, an estimated $11.6M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Zacks Investment Management's largest Q3 2013 buy was PNC Financial Services: 123,980 shares worth $8.98M.
  • Zacks Investment Management added most to Lear in Q3 2013, an estimated $8.83M increase.
  • Zacks Investment Management's biggest Q3 2013 reduction was M.D.C. Holdings, Inc., cutting an estimated $7.35M.
  • Zacks Investment Management fully exited Mattel in Q3 2013, selling an estimated $11.6M.
  • Zacks Investment Management's ten largest holdings make up 16% of its $2.31B portfolio in Q3 2013.
  • Zacks Investment Management opened 110 new positions and closed 75 in Q3 2013.
  • Zacks Investment Management's portfolio value rose 6.2% quarter-over-quarter to $2.31B.

Based on Zacks Investment Management's 13F filing for Q3 2013, filed 13 Nov 2013.